Allergan Stock Buy Or Sell May 2026

As of April 2026, . The company was acquired by AbbVie (NYSE: ABBV) in a $63 billion deal that officially closed on May 8, 2020.

Since the acquisition, AbbVie has used Allergan’s aesthetics and neuroscience portfolios to diversify its revenue. allergan stock buy or sell

If you previously held Allergan (AGN) shares, they were converted during the 2020 merger according to the following terms: AbbVie Completes Transformative Acquisition of Allergan As of April 2026,

Because Allergan has been integrated into AbbVie, you can no longer buy or sell "AGN" shares directly. Instead, investors seeking exposure to Allergan's former portfolio—including and Juvederm —must now trade AbbVie stock. Investment Profile for AbbVie (ABBV) If you previously held Allergan (AGN) shares, they

: For the full year 2026, management has guided for net revenues of approximately $67 billion, representing 9.5% growth. Historical Acquisition Terms